首页> 外文期刊>Journal of cellular biochemistry. >Activation of spinal Extacellular Signal‐Regulated Kinases and c‐jun N‐terminal kinase signaling pathways contributes to morphine‐induced acute and chronic hyperalgesia in mice
【24h】

Activation of spinal Extacellular Signal‐Regulated Kinases and c‐jun N‐terminal kinase signaling pathways contributes to morphine‐induced acute and chronic hyperalgesia in mice

机译:脊柱偏离信号调节激酶和C-JUM N-末端激酶信号传导途径的激活有助于对小鼠的吗啡诱导的急性和慢性痛觉过敏

获取原文
获取原文并翻译 | 示例
       

摘要

Abstract Background This study investigated the activation of mitogen‐activated protein kinases in the spinal dorsal horn to explore the mechanisms underlying morphine‐induced acute and chronic hyperalgesia in mice. Methods Male adult mice were given a single subcutaneous injection (SC) of morphine (1?μg/kg) or twice‐daily administration of morphine (10?mg/kg/day) for 8 days. Thermal hyperalgesia and mechanical allodynia were assessed using the radiant heat and von Frey filament test. Levels of phospho (p)‐extracellular signal–regulated kinases (p‐ERK), p‐c‐Jun N‐terminal kinase (p‐JNK), p‐p38, p‐PKCγ, N ‐methyl‐ d ‐aspartate receptor (NMDAr), and c‐Fos protein in the spinal dorsal horn were examined by Western blot assays. Results A single ultra‐low dose or repeated administration of morphine induced hyperalgesia in mice and caused a significant increase in the levels of p‐ERK and p‐JNK, but not p‐p38, in the spinal dorsal horn. The level of c‐Fos protein was significantly elevated following administration of morphine. The protein levels of p‐PKCγ and NMDAr subunits (NR2B and NR2A) were also altered. Pretreatment with the NMDAr antagonist MK‐801 or the protein kinase C (PKC) inhibitor calphostin C (CC) suppressed the morphine‐induced increase in p‐ERK, p‐JNK, and c‐Fos. Administration of MK‐801 and CC also relieved morphine‐induced hyperalgesia. Conclusion These findings suggest that activation of the spinal ERK and JNK signaling pathways contribute to morphine‐induced acute and chronic hyperalgesia in mice.
机译:摘要背景本研究调查了脊髓背角中丝裂剂活化蛋白激酶的激活,探讨了大鼠吗啡诱导的急性和慢性痛觉过敏性潜在的机制。方法将阳性成年小鼠进行一次皮下注射(SC)吗啡(1〜μg/ kg)或每日两次给药吗啡(10?mg / kg /天)8天。使用辐射热和von Frey灯丝测试评估热痛觉体和机械异常。磷酸含量水平(P) - Xtracellular信号调节激酶(P-ERK),P-C-JUN N-末端激酶(P-JNK),P-P38,P-PKCγ,N-甲基-D-海地受体( NMDAR)和脊髓背角中的C-FOS蛋白通过Western印迹测定检查。结果单个超低剂量或反复施用的吗啡诱导小鼠的痛觉痛觉痛觉痛觉疗程,并导致P-ERK和P-JNK水平的显着增加,但不是P-P38,在脊椎背角中。在给予吗啡施用后,C-FOS蛋白的水平显着升高。还改变了p-PKCγ和NMDAR亚基(NR2B和NR2A)的蛋白质水平。用NMDAR拮抗剂MK-801或蛋白激酶C(PKC)抑制剂葫芦蛋白C(CC)的预处理抑制了对吗啡诱导的P-ERK,P-JNK和C-FOS的增加。 MK-801和CC的给药也缓解了吗啡诱导的痛觉过敏。结论这些研究结果表明,脊柱ERK和JNK信号传导途径的激活有助于对小鼠的吗啡诱导的急性和慢性痛觉过敏。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号